Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Successful Pregnancy in a Patient with Infertility Due to Congenital Plasminogen Deficiency Treated with Intravenous Plasminogen (Human) Replacement Therapy

Anne Flem Jacobsen, MD, Joseph M Parker, MD, Diane Trybul, BS, Per Morten Sandset, MD

Blood (2020) 136 (Supplement 1): 5–6.

https://doi.org/10.1182/blood-2020-135847

Published: 2020

Journal Articles

Painting the Clinical Picture of Congenital Plasminogen Deficiency (C-PLGD) through a Comprehensive Case Study Review

Karen Thibaudeau, PhD, Martin Robitaille, PhD, Victoria Ledsham, MS, Per Morten Sandset, MD

Blood (2020) 136 (Supplement 1): 21–22.

https://doi.org/10.1182/blood-2020-137690

Published: 2020

Journal Articles

Pivotal Trial with Intravenous Plasminogen Replacement in Patients with Plasminogen Deficiency Demonstrates Long-Term Efficacy for Treatment and Prevention of Ligneous Lesions

Charles T Nakar, MD, Joseph M Parker, MD, Neelam Thakral, Brandon M. Hardesty, MD, Gary Albert, Pierre Laurin, MSc, BPharm, John Moran, MD, Per Morten Sandset, MD PhD, Amy D. Shapiro, MD

Blood (2017) 130 (Supplement 1): 84.

https://doi.org/10.1182/blood.V130.Suppl_1.84.84

Published: 2017

Journal Articles

Improved Functional Outcome After Additional Catheter-Directed Thrombolysis for Acute Iliofemoral Deep Vein Thrombosis: Results of a Randomized Controlled Clinical Trial (The CaVenT Study)

Tone Rønnaug Enden, MD, PhD, Ylva Haig, MD, Nils-Einar Kløw, MD, PhD, Carl Erik Slagsvold, MD, PhD, Leiv Sandvik, PhD, Waleed Ghanima, MD, PhD, Geir Hafsahl, MD, PhD, Pål Andre Holme, MD, PhD, Lars Olaf Holmen, MD, Anne Mette Njaastad, MD, Gunnar Sandbaek, MD, PhD, Per Morten Sandset, MD, PhD

Blood (2011) 118 (21): LBA-1.

https://doi.org/10.1182/blood.V118.21.LBA-1.LBA-1

Published: 2011

Journal Articles

Candidate Gene Polymorphisms and the Risk for Pregnancy Related Venous Thrombosis

Anders E. A. Dahm, PhD, Irene D. Bezemer, PhD, Astrid Bergrem, PhD, Anne Flem Jacobsen, PhD, Eva Marie Jacobsen, PhD, Grethe Skretting, Frits Rosendaal, MD, PhD, Per Morten Sandset, MD, PhD

Blood (2010) 116 (21): 4203.

https://doi.org/10.1182/blood.V116.21.4203.4203

Published: 2010

Journal Articles

Increased Bone Marrow Microvascular Density in Hematologic Malignancies

Helene Francisca Stigter Negaard, MD, Nina Iversen, PhD, Inger Marie Bowitz-Lothe, MD, Per Morten Sandset, MD, PhD, Brit Steinsvik, Bjørn Østenstad, MD, PhD, Per Ole Iversen, MD, PhD

Blood (2008) 112 (11): 5456.

https://doi.org/10.1182/blood.V112.11.5456.5456

Published: 2008

Journal Articles

Adjunctive Catheter-Directed Venous Thrombolysis in Iliofemoral Deep Vein Thrombosis; Short-Term Results from the CaVenT Study, a Multicenter Randomized Controlled Trial

Tone Rønnaug Enden, MD, Carl-Erik Slagsvold, MD, PhD, Nils-Einar Kløw, MD, PhD, Per Morten Sandset, MD, PhD

Blood (2008) 112 (11): 989.

https://doi.org/10.1182/blood.V112.11.989.989

Published: 2008

Journal Articles

Production of Tissue Factor Pathway Inhibitor in Endothelial Cell Cultures Is Reduced by Estrogens, Selective Estrogen Receptor Modifiers, and a Selective Estrogen Receptor Downregulator.

Anders E.A. Dahm, MD, Nina Iversen, PhD, Baard Birkenes, Per Morten Sandset, MD, PhD

Blood (2005) 106 (11): 3961.

https://doi.org/10.1182/blood.V106.11.3961.3961

Published: 2005

Journal Articles

Biological Relevance of a New TFPI Anticoagulant Activity Assay of Full-Length TFPI.

Anders E.A. Dahm, MD, Trine O. Andersen, Frits Rosendaal, MD, PhD, Per Morten Sandset, MD, PhD

Blood (2004) 104 (11): 2982.

https://doi.org/10.1182/blood.V104.11.2982.2982

Published: 2004

Journal Articles

A Fast Track Strategy for Managing Suspected Pulmonary Embolism (PE) in Outpatients.

Waleed Ghanima, MD, Vibeke Almaas, MD, Saad Aballi, MD, Dorje Christina, MD, Per Morten Sandset, MD, PhD

Blood (2004) 104 (11): 1766.

https://doi.org/10.1182/blood.V104.11.1766.1766

Published: 2004

Journal Articles

A Novel Assay for Tissue Factor Pathway Inhibitor (TFPI) Anticoagulant Activity in Plasma.

Anders E.A. Dahm, MD, Trine O. Andersen, Frits Rosendaal, MD, PhD, Per Morten Sandset, MD, PhD

Blood (2004) 104 (11): 3987.

https://doi.org/10.1182/blood.V104.11.3987.3987

Published: 2004

NARROW

Successful Pregnancy in a Patient with Infertility Due to Congenital Plasminogen Deficiency Treated with Intravenous Plasminogen (Human) Replacement Therapy

Painting the Clinical Picture of Congenital Plasminogen Deficiency (C-PLGD) through a Comprehensive Case Study Review

Pivotal Trial with Intravenous Plasminogen Replacement in Patients with Plasminogen Deficiency Demonstrates Long-Term Efficacy for Treatment and Prevention of Ligneous Lesions

Improved Functional Outcome After Additional Catheter-Directed Thrombolysis for Acute Iliofemoral Deep Vein Thrombosis: Results of a Randomized Controlled Clinical Trial (The CaVenT Study)

Candidate Gene Polymorphisms and the Risk for Pregnancy Related Venous Thrombosis

Increased Bone Marrow Microvascular Density in Hematologic Malignancies

Adjunctive Catheter-Directed Venous Thrombolysis in Iliofemoral Deep Vein Thrombosis; Short-Term Results from the CaVenT Study, a Multicenter Randomized Controlled Trial

Production of Tissue Factor Pathway Inhibitor in Endothelial Cell Cultures Is Reduced by Estrogens, Selective Estrogen Receptor Modifiers, and a Selective Estrogen Receptor Downregulator.

Biological Relevance of a New TFPI Anticoagulant Activity Assay of Full-Length TFPI.

A Fast Track Strategy for Managing Suspected Pulmonary Embolism (PE) in Outpatients.

A Novel Assay for Tissue Factor Pathway Inhibitor (TFPI) Anticoagulant Activity in Plasma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only